News
CFDA's Vice Minister Mr. Sun Xianze a...
2018-01-11
CFDA’s Vice Minister, Mr Sun Xianze, and thePresident of National Institute for Food and Drug Control, Dr Li Bo, visited Beijing Sciecure on January 11, 2018
- Marketing Authorization(ANDA) of Budesonide Capsule 3mg is granted by US FDA2017-09-28
- Beijing Sciecure Successfully Passing GMP Audit by Teva2017-09-11
- Beijing Sciecure is successful in US FDA inspection2017-08-04
- Marketing Authorization (MA) of Valsartan Hydrochlorothiazide 80/12.5mg, 160/12...2017-08-01
- Marketing Authorization (MA) of Levetiracetam Sciecure 250mg, 500mg, 750mg and 1000mg film-coated Tablets are granted by UK MHRA2017-07-18
- Marketing Authorization (MA) of Valsartan 40mg, 80mg, 160mg and 320mg film-coated Tablets are granted by UK MHRA2017-06-14
- Marketing Authorization (MA) of Candesartan Cilexetil 2mg, 4mg, 8mg, 16mg, 32mg Tablets are granted by UK MHRA2017-05-10
- Marketing Authorization (MA) of Levetiracetam Sciecure 100mg/ml concentrate for solution for infusion is granted by UK MHRA2017-02-20
- Marketing Authorization（MA）of Levetiracetam 100mg/ml concentrate for solution...2017-02-06
- Marketing Authorization（MA）of Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200...2017-02-06
BeiJing Sciecure Pharmaceutical Co. Ltd., Contact info: 010-60447688
Address: Zhongbei Industrial Park, Beishicao Town, Shunyi District, Beijing, China.
